tiprankstipranks
Advertisement
Advertisement
Teva price target raised to $40 from $35 at JPMorgan
PremiumThe FlyTeva price target raised to $40 from $35 at JPMorgan
22d ago
Teva price target raised to $42 from $41 at Piper Sandler
Premium
The Fly
Teva price target raised to $42 from $41 at Piper Sandler
22d ago
Teva price target raised to $42 from $36 at UBS
Premium
The Fly
Teva price target raised to $42 from $36 at UBS
22d ago
Teva says ‘on track’ to achieve 2027 financial targets
PremiumThe FlyTeva says ‘on track’ to achieve 2027 financial targets
23d ago
Teva says has greater than $10B of innovative pipeline potential
Premium
The Fly
Teva says has greater than $10B of innovative pipeline potential
23d ago
Teva seeing ‘significant progress’ with transformation programs
Premium
The Fly
Teva seeing ‘significant progress’ with transformation programs
23d ago
Teva to acquire Emalex Biosciences for $700M at closing
PremiumThe FlyTeva to acquire Emalex Biosciences for $700M at closing
23d ago
Notable companies reporting before tomorrow’s open
Premium
The Fly
Notable companies reporting before tomorrow’s open
24d ago
Teva put volume heavy and directionally bearish
Premium
The Fly
Teva put volume heavy and directionally bearish
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100